Abstract
Improvements in Glomerular Filtration Rate (GFR) in Chronic Kidney Disease (CKD) Patients Using a Commercial Patented and Proprietary ProbioticPrebiotic Formulation* -3rd Biennial Survey
Highlights
Chronic Kidney Disease (CKD) refers to a wide range of conditions which damage the kidneys, and reduce their efficiency to filter the blood [1]
Since the FDA/National Kidney Foundation (NKF) guideline mandated the primary endpoints in CKD treatments/therapies is to reduce the decline of Glomerular Filtration Rate (GFR) by 30% (40% is preferred), we extended this third biennial survey with GFR in mind
Chronic kidney disease is generally recognized as a degenerative process
Summary
Chronic Kidney Disease (CKD) refers to a wide range of conditions which damage the kidneys, and reduce their efficiency to filter the blood [1]. CKD is a chronic condition, meaning kidney function continues to decline over time, and the disease generally cannot be prevented or cured by medication/treatment [2]. Increases in blood pressure increase the rate of decline in kidney function by damaging nephrons and glomeruli [7]. Available since 2010, it is continually being studied to assess its effectiveness This survey was to evaluate GFR changes as measured in mL/min per 1.73 m2, and quality of life (QoL) improvements in customers taking this synbiotic dietary supplement along with their standard care of therapy
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
